ReShape Lifesciences Price Patterns
| RSLSDelisted Stock | USD 15.68 3.60 29.80% |
Momentum 43
Sell Extended
Oversold | Overbought |
Using ReShape Lifesciences hype-based prediction, you can estimate the value of ReShape Lifesciences from the perspective of ReShape Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ReShape Lifesciences to buy its stock at a price that has no basis in reality. In that case, they are not buying ReShape because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ReShape Lifesciences after-hype prediction price | USD 15.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ReShape |
ReShape Lifesciences After-Hype Price Density Analysis
As far as predicting the price of ReShape Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ReShape Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ReShape Lifesciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ReShape Lifesciences Estimiated After-Hype Price Volatility
In the context of predicting ReShape Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ReShape Lifesciences' historical news coverage. ReShape Lifesciences' after-hype downside and upside margins for the prediction period are 15.68 and 15.68, respectively. We have considered ReShape Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ReShape Lifesciences is very steady at this time. Analysis and calculation of next after-hype price of ReShape Lifesciences is based on 3 months time horizon.
ReShape Lifesciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ReShape Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ReShape Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ReShape Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 7 Events / Month | 1 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
15.68 | 15.68 | 0.00 |
|
ReShape Lifesciences Hype Timeline
ReShape Lifesciences is at this time traded for 15.68. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ReShape is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on ReShape Lifesciences is about 0.0%, with the expected price after the next announcement by competition of 15.68. The company recorded a loss per share of 830.44. ReShape Lifesciences last dividend was issued on the 25th of July 2019. The entity had 1:4 split on the 15th of August 2025. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.ReShape Lifesciences Related Hype Analysis
Having access to credible news sources related to ReShape Lifesciences' direct competition is more important than ever and may enhance your ability to predict ReShape Lifesciences' future price movements. Getting to know how ReShape Lifesciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ReShape Lifesciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SIEN | Sientra | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CUTR | Cutera Inc | 0.00 | 10 per month | 0.00 | (0.11) | 20.00 | (15.38) | 90.46 | |
| ATNX | Athenex | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NTBL | Notable Labs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FRES | Fresh2 Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PTN | Palatin Technologies | (0.65) | 2 per month | 7.28 | 0.12 | 26.61 | (12.36) | 75.34 | |
| SQL | SeqLL Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EIGRQ | Eiger BioPharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GMVD | G Medical Innovations | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PLXP | PLx Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ReShape Lifesciences Additional Predictive Modules
Most predictive techniques to examine ReShape price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ReShape using various technical indicators. When you analyze ReShape charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ReShape Lifesciences Predictive Indicators
The successful prediction of ReShape Lifesciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ReShape Lifesciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ReShape Lifesciences based on analysis of ReShape Lifesciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ReShape Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ReShape Lifesciences's related companies.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in ReShape Stock
If you are still planning to invest in ReShape Lifesciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ReShape Lifesciences' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |